James Powers is currently a board member at Virginia Bio. James was previously the Chairman and CEO of HemoShear Therapeutics, Inc. from January 2008 to July 2022. HemoShear Therapeutics discovers novel biological targets and advances drug programs to treat metabolic disorders with significant unmet patient need.
Powers was also the Executive Vice President at PRA International, Inc. from January 1988 to December 2006.
James Powers has a B.S. in Management Science from Carnegie Mellon University and attended Xavier High School.